Zapping Zika in the Brin
Zapping Zika in the Brain: NTU Researchers Pioneer Peptide-Based Treatment
Declared a global health emergency in 2016 by the World Health Organisation, the Zika virus drew worldwide concern after infections were linked to severe birth defects, including microcephaly in newborns. Now, researchers from Nanyang Technological University, Singapore (NTU), are taking critical steps toward combating this threat.
A team led by Professor Cho Nam-Joon from NTU’s School of Materials Science and Engineering has developed bioactive peptides—short chains of amino acids—that can rupture the protective lipid envelope of the Zika virus. Notably, the team’s lead peptide was shown to cross the blood-brain barrier in Zika-infected mice, eliminating the virus from the brain and improving survival rates.
This innovative approach also holds promise against other mosquito-borne viruses such as dengue and chikungunya. The peptide has been licensed to NTU spin-off company TSG Therapeutics, with plans for further testing in larger animals before moving toward clinical trials.
Read the full article on NTU Discoveries: Zapping Zika in the Brain.
The study “Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide” was published in Nature Materials (2018), DOI: 10.1038/s41563-018-0194-2.


